187 related articles for article (PubMed ID: 20350350)
1. Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain.
Robinson AJ; Zhao G; Rathjen J; Rathjen PD; Hutchinson RG; Eyre HJ; Hemsley KM; Hopwood JJ
Cell Transplant; 2010; 19(8):985-98. PubMed ID: 20350350
[TBL] [Abstract][Full Text] [Related]
2. Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA.
Rozaklis T; Beard H; Hassiotis S; Garcia AR; Tonini M; Luck A; Pan J; Lamsa JC; Hopwood JJ; Hemsley KM
Exp Neurol; 2011 Jul; 230(1):123-30. PubMed ID: 21515264
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA.
Savas PS; Hemsley KM; Hopwood JJ
Mol Genet Metab; 2004 Aug; 82(4):273-85. PubMed ID: 15308125
[TBL] [Abstract][Full Text] [Related]
4. Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.
Hemsley KM; King B; Hopwood JJ
Mol Genet Metab; 2007 Mar; 90(3):313-28. PubMed ID: 17166757
[TBL] [Abstract][Full Text] [Related]
5. Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.
Lau AA; Hemsley KM; Meedeniya A; Robinson AJ; Hopwood JJ
Methods Mol Biol; 2006; 329():471-84. PubMed ID: 16846011
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
Perkins KJ; Muller V; Weber B; Hopwood JJ
Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.
Crawley AC; Gliddon BL; Auclair D; Brodie SL; Hirte C; King BM; Fuller M; Hemsley KM; Hopwood JJ
Brain Res; 2006 Aug; 1104(1):1-17. PubMed ID: 16828069
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of genetically modified embryonic stem cells as a therapy for murine mucopolysaccharidosis type IIIA.
Lau AA; Hemsley KM; Meedeniya A; Hopwood JJ
Mol Genet Metab; 2004 Feb; 81(2):86-95. PubMed ID: 14741188
[TBL] [Abstract][Full Text] [Related]
9. Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs--a proof of principle study.
Hemsley KM; Norman EJ; Crawley AC; Auclair D; King B; Fuller M; Lang DL; Dean CJ; Jolly RD; Hopwood JJ
Mol Genet Metab; 2009 Dec; 98(4):383-92. PubMed ID: 19699666
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of embryonic neural stem/precursor cells overexpressing BM88/Cend1 enhances the generation of neuronal cells in the injured mouse cortex.
Makri G; Lavdas AA; Katsimpardi L; Charneau P; Thomaidou D; Matsas R
Stem Cells; 2010 Jan; 28(1):127-39. PubMed ID: 19911428
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice.
Gliddon BL; Hopwood JJ
Pediatr Res; 2004 Jul; 56(1):65-72. PubMed ID: 15128919
[TBL] [Abstract][Full Text] [Related]
13. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes.
Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ
Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of recombinant murine sulfamidase.
Gliddon BL; Yogalingam G; Hopwood JJ
Mol Genet Metab; 2004 Nov; 83(3):239-45. PubMed ID: 15542395
[TBL] [Abstract][Full Text] [Related]
15. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B.
Garbuzova-Davis S; Klasko SK; Sanberg PR
J Comp Neurol; 2009 Jul; 515(1):93-101. PubMed ID: 19399896
[TBL] [Abstract][Full Text] [Related]
16. Behavioral improvement after transplantation of neural precursors derived from embryonic stem cells into the globally ischemic brain of adolescent rats.
Kang HC; Kim DS; Kim JY; Kim HS; Lim BY; Kim HD; Lee JS; Eun BL; Kim DW
Brain Dev; 2010 Sep; 32(8):658-68. PubMed ID: 19854013
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA.
Roberts AL; Howarth GS; Liaw WC; Moretta S; Kritas S; Lymn KA; Yazbeck R; Tran C; Fletcher JM; Butler RN; Byers S
J Cell Physiol; 2009 May; 219(2):259-64. PubMed ID: 19170061
[TBL] [Abstract][Full Text] [Related]
18. Long-term fate of neural precursor cells following transplantation into developing and adult CNS.
Lepore AC; Neuhuber B; Connors TM; Han SS; Liu Y; Daniels MP; Rao MS; Fischer I
Neuroscience; 2006 May; 139(2):513-30. PubMed ID: 16458439
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of radial glia-like cells from embryonic stem cells.
Liour SS; Yu RK
Glia; 2003 Apr; 42(2):109-17. PubMed ID: 12655595
[TBL] [Abstract][Full Text] [Related]
20. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy.
Klein D; Schmandt T; Muth-Köhne E; Perez-Bouza A; Segschneider M; Gieselmann V; Brüstle O
Gene Ther; 2006 Dec; 13(24):1686-95. PubMed ID: 16871228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
